Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome

E R Alpern1, E A Alessandrini, L M Bell

  • 1Division of Emergency Medicine, Children's Hospital of Philadelphia, Pennsylvania 19104, USA. alpern@email.chop.edu

Pediatrics
|September 2, 2000
PubMed

Insights

Occult bacteremia in children is less common post-Haemophilus influenzae type b vaccine. Streptococcus pneumoniae is the main cause, usually resolving without antibiotics, with rare serious outcomes.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Occult bacteremia, particularly in young children, has been a concern for bloodstream infections.
  • The introduction of the Haemophilus influenzae type b (Hib) vaccine has potentially altered the epidemiology of bacteremia.

Purpose of the Study:

  • To assess the current prevalence and characteristics of occult bacteremia in children.
  • To identify the predominant pathogens and evaluate outcomes in the post-Hib vaccine era.

Main Methods:

  • A retrospective cohort study of 5901 febrile children (2-24 months) with blood cultures was conducted.
  • Exclusion criteria included immunosuppression, focal infection, or lumbar puncture.
  • Prevalence, pathogen distribution, and time to positive culture were analyzed.

Main Results:

  • Occult bacteremia prevalence was 1.9%, with Streptococcus pneumoniae being the most common pathogen (82.9%).
  • Haemophilus influenzae was not identified as a cause.
  • Cultures positive within 18 hours were more likely to be pathogenic; most pneumococcal cases resolved without antibiotics.

Conclusions:

  • Occult bacteremia is less prevalent post-Hib vaccine, with S. pneumoniae dominating and typically resolving favorably.
  • Continuous blood culture monitoring aids in pathogen identification.
  • Serious adverse outcomes are rare, but updated epidemiology influences management strategies.
Abstract